Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Helix BioPharma Corp. Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial
Helix BioPharma Corp. Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial
Helix BioPharma Corp. Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial
Submitted by
moderatorj
on October 12, 2011 - 8:42pm
Source:
Yahoo/MarketWire
News Tags:
Helix BioPharma
FDA
clinical trial
Headline:
Helix BioPharma Corp. Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial
Do Not Allow Advertisers to Use My Personal information